Human IgG antibody Laboratories manufactures the cynomolgus monkey cross-reactive antibody 4-1bb reagents distributed by Genprice. The Cynomolgus Monkey Cross-Reactive Antibody 4-1Bb reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact monkey Antibody. Other Cynomolgus products are available in stock. Specificity: Cynomolgus Category: Monkey Group: Cross-Reactive Antibody
Cross-Reactive Antibody information
CD137 Antibody / 4-1BB / TNFRSF9 |
|||
| V8636-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma. |
|||
CD137 Antibody / 4-1BB / TNFRSF9 |
|||
| V8636-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma. |
|||
CD137 Antibody / 4-1BB / TNFRSF9 |
|||
| V8636SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma. |
|||
CD137 Antibody / 4-1BB / TNFRSF9 |
|||
| V7531-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma. |
|||
CD137 Antibody / 4-1BB / TNFRSF9 |
|||
| V7531-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma. |
|||
CD137 Antibody / 4-1BB / TNFRSF9 |
|||
| V7531IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma. |
|||
CD137 Antibody / 4-1BB / TNFRSF9 |
|||
| V7531SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma. |
|||
CD137 Antibody / 4-1BB / TNFRSF9 |
|||
| V7567-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma. |
|||
CD137 Antibody / 4-1BB / TNFRSF9 |
|||
| V7567-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma. |
|||
CD137 Antibody / 4-1BB / TNFRSF9 |
|||
| V7567BTN | NSJ Bioreagents | 500 ul | EUR 499 |
|
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma. |
|||
CD137 Antibody / 4-1BB / TNFRSF9 |
|||
| V7567IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma. |
|||
CD137 Antibody / 4-1BB / TNFRSF9 |
|||
| V7567SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma. |
|||
CD137 Antibody / 4-1BB / TNFRSF9 |
|||
| V8061-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma. |
|||
CD137 Antibody / 4-1BB / TNFRSF9 |
|||
| V8061-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma. |
|||
CD137 Antibody / 4-1BB / TNFRSF9 |
|||
| V8061SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma. |
|||
Anti-C Reactive Protein/CRP Antibody |
|||
| A00249-4 | BosterBio | 100ug/vial | EUR 400.8 |
Cynomolgus / Rhesus macaque 4-1BB / TNFRSF9 Protein (Leu 24-Gln 186) [His] |
|||
| VAng-0686Lsx-100g | Creative Biolabs | 100 µg | EUR 1215.6 |
|
Description: Cynomolgus / Rhesus macaque 4-1BB, His tag, was expressed in HEK 293 cells, with a molecular weight of 19.2 kDa. (Uniprot ID: XP_005544945.1) |
|||